Lobbying

Zelis Healthcare's latest lobbying report covers Q2 2026, at $150K. The four quarters Q4 2025–Q3 2026 total $410K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Zelis Healthcare

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$410K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Zelis Healthcare lobbying by quarter
Zelis Healthcare lobbying by quarter
QuarterAmountReports
Q4 2022$50K2
Q1 2023$50K2
Q2 2023$50K2
Q3 2023$50K2
Q4 2023$50K2
Q1 2024$50K2
Q2 2024$60K1
Q3 2024$60K1
Q4 2024$60K1
Q1 2025$100K1
Q2 2025$100K1
Q3 2025$110K1
Q4 2025$110K1
Q1 2026$150K1
Q2 2026$150K1
Q3 2026$00

By issue

  • Health issues$1.1M · 15 reports
  • Medicare and Medicaid$125K · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES11 reports
  • SENATE11 reports
  • Centers For Medicare and Medicaid Services (CMS)5 reports
  • Office of Management & Budget (OMB)3 reports
  • White House Office3 reports
  • Health & Human Services, Dept of (HHS)1 reports

Firms it paid

Firm
Akin Gump Strauss Hauer & Feld$900K15 quarters
Avenue Solutions$300K6 quarters

Former officials lobbying for it

Former position
MARA LEFEVRELeg. Asst., Sen. Hoeven (2025-2026); Leg. Aide, Sen. Hoeven (2025); Leg. Cor., Sen. Hoeven (2023-2024); Staff Asst., Sen. Hoeven (2022-2023); Intern, Sen. KCramer (2020).Q2 2026
MIA HECKConfidential Asst. to Asst. Sec Pub. Affairs, ASPA, HHS (9/02 - 3/04); Dir. Special Proj., IOS, HHS (1/05 - 2/06); Snr Adv. to Administrator, CMS, HHS (10/17 - 1/18); Snr Adv., IEA, HHS (1/18 - 6/19); Dir. External Affairs, OASH, HSS (6/19-1/21)Q3 2025
SHAWN MAREE BISHOPChief Health Advisor, US Sen. Finance Comm. (2/16/21-11/15/2024); Senior Advisor, US Sen. Finance Comm. (5/6/19 - 10/1/19); Professional Staff, US Sen. Finance Comm. (2/5/2005-10/1/2010).Q3 2025
ANNA ABRAMDpty Comm, Pol, Leg, Intnl Affrs, FDA, Mar19Jan21; Mar17Mar19; Spcl Asst HHS, Jan21Mar17; Dec09Jan21; Hlth Dirctr, Sen Burr, Sen Hlth, L&P Comm, Apr09Dec09; Stff Mbr, Sen VA Comm, Feb09Apr09; AsstDrctr, WH Jan0709; LA, LC, SA, SenSantorum, May03Dec06Q2 2024

Lobbying reports

Filed by
07/20for Q2Akin Gump Strauss Hauer & Feld$150K
04/20for Q1Akin Gump Strauss Hauer & Feld$150K
01/20for Q4 2025Akin Gump Strauss Hauer & Feld$110K
25/10/20for Q3 2025Akin Gump Strauss Hauer & Feld$110K
25/07/21for Q2 2025Akin Gump Strauss Hauer & Feld$100K
25/04/21for Q1 2025Akin Gump Strauss Hauer & Feld$100K
25/01/21for Q4 2024Akin Gump Strauss Hauer & Feld$60K
24/10/18for Q3 2024Akin Gump Strauss Hauer & Feld$60K
24/07/19for Q2 2024Akin Gump Strauss Hauer & Feld$60K
24/05/03for Q2 2024Akin Gump Strauss Hauer & FeldUnder $5,000
24/04/22for Q1 2024Avenue Solutions$50K
24/03/29for Q1 2024Akin Gump Strauss Hauer & FeldUnder $5,000
24/01/22for Q4 2023Avenue Solutions$50K
24/01/19for Q4 2023Akin Gump Strauss Hauer & FeldUnder $5,000
23/10/20for Q3 2023Avenue Solutions$50K
23/10/20for Q3 2023Akin Gump Strauss Hauer & FeldUnder $5,000
23/07/20for Q2 2023Akin Gump Strauss Hauer & FeldUnder $5,000
23/07/19for Q2 2023Avenue Solutions$50K
23/04/20for Q1 2023Avenue Solutions$50K
23/04/20for Q1 2023Akin Gump Strauss Hauer & FeldUnder $5,000